PureTech News

Sign up for
email alerts

To receive news as it is released, please sign up.

Press releases
Press Releases - 2022-03-16
PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Press Releases - 2022-03-08
PureTech Founded Entity Akili Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
Press Releases - 2022-02-17
PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
Press Releases - 2022-02-15
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
Press Releases - 2022-02-10
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Press Releases - 2022-01-31
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
Press Releases - 2022-01-26
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
Press Releases - 2022-01-14
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
Press Releases - 2022-01-07
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
Press Releases - 2022-01-06
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
Displaying 51 - 60 of 329